The Importance of CXCL1 in Physiology and Noncancerous Diseases of Bone, Bone Marrow, Muscle and the Nervous System.
Jan KorbeckiMagdalena Gąssowska-DobrowolskaJerzy WójcikIwona SzatkowskaKatarzyna BarczakMikołaj ChlubekIrena Baranowska-BosiackaPublished in: International journal of molecular sciences (2022)
This review describes the role of CXCL1, a chemokine crucial in inflammation as a chemoattractant for neutrophils, in physiology and in selected major non-cancer diseases. Due to the vast amount of available information, we focus on the role CXCL1 plays in the physiology of bones, bone marrow, muscle and the nervous system. For this reason, we describe its effects on hematopoietic stem cells, myoblasts, oligodendrocyte progenitors and osteoclast precursors. We also present the involvement of CXCL1 in diseases of selected tissues and organs including Alzheimer's disease, epilepsy, herpes simplex virus type 1 (HSV-1) encephalitis, ischemic stroke, major depression, multiple sclerosis, neuromyelitis optica, neuropathic pain, osteoporosis, prion diseases, rheumatoid arthritis, tick-borne encephalitis (TBE), traumatic spinal cord injury and West Nile fever.
Keyphrases
- spinal cord injury
- bone marrow
- neuropathic pain
- herpes simplex virus
- stem cells
- multiple sclerosis
- spinal cord
- rheumatoid arthritis
- mesenchymal stem cells
- bone mineral density
- papillary thyroid
- squamous cell carcinoma
- atrial fibrillation
- postmenopausal women
- systemic lupus erythematosus
- healthcare
- disease activity
- cognitive decline
- young adults
- bone loss
- white matter
- idiopathic pulmonary fibrosis
- cell therapy
- interstitial lung disease
- health information
- temporal lobe epilepsy